|
Market Closed -
Nasdaq
00:00:00 25/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 3.880 USD | +5.43% |
|
+10.54% | -6.73% |
Evolution of the Average Target: Galectin Therapeutics Inc.
Evolution of the Target Price: Galectin Therapeutics Inc.
Changes in Analyst Recommendations: Galectin Therapeutics Inc.
c1851a5fe462e9a6398.svI7cFu7kbQnjLmMTd-L7wM4HtpBAzxGfha0B8CroIU.wJx1QCno5_11__v4HO_xi3YKRJ4QQGkcMEfBbrDojbT1lFQaA4Pf3Eqh1g~586d54e6f253b1d5e8d0e519d955672e
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +183.51% | |||
| +15.88% | |||||
| +6.57% | |||||
| +5.74% | |||||
| +16.18% | |||||
| +37.13% | |||||
| -6.16% | |||||
| +24.17% | |||||
| -1% | |||||
| -5.89% | |||||
| Average | +27.61% | |||||
| Weighted average by Cap. | +12.63% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.880USD
Average target price
11.00USD
Spread / Average Target
+183.51%
High Price Target
11.00USD
Spread / Highest target
+183.51%
Low Price Target
11.00USD
Spread / Lowest Target
+183.51%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| HC Wainwright |
SellBuy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.880USD
Average target price
11.00USD
Spread / Average Target
+183.51%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GALT Stock
- Consensus Galectin Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
